ID
22139
Beschrijving
Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00466284
Link
https://clinicaltrials.gov/show/NCT00466284
Trefwoorden
Versies (1)
- 21-05-17 21-05-17 -
Geüploaded op
21 mei 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non-Small Cell Lung Cancer NCT00466284
Eligibility Non-Small Cell Lung Cancer NCT00466284
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
Investigational New Drugs
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013230
Beschrijving
erlotinib | Epidermal growth factor receptor inhibitor
Datatype
boolean
Alias
- UMLS CUI [1]
- C1135135
- UMLS CUI [2]
- C1443775
Beschrijving
Comorbidity Significant
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0750502
Similar models
Eligibility Non-Small Cell Lung Cancer NCT00466284
- StudyEvent: Eligibility
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0031843 (UMLS CUI [1,2])
C0023508 (UMLS CUI [2])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0201850 (UMLS CUI [5])
C0201976 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C1443775 (UMLS CUI [2])
C0750502 (UMLS CUI [1,2])